|
IL61904A
(en)
|
1981-01-13 |
1985-07-31 |
Yeda Res & Dev |
Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
|
|
US4659669A
(en)
|
1981-03-02 |
1987-04-21 |
Regents Of The Univ. Of California |
Microbial expression of human influenza hemagglutinin proteins
|
|
US4533254A
(en)
|
1981-04-17 |
1985-08-06 |
Biotechnology Development Corporation |
Apparatus for forming emulsions
|
|
US4625015A
(en)
|
1982-08-23 |
1986-11-25 |
Scripps Clinic & Research Foundation |
Broad spectrum influenza antisera
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US4728575A
(en)
|
1984-04-27 |
1988-03-01 |
Vestar, Inc. |
Contrast agents for NMR imaging
|
|
US4752473A
(en)
|
1984-10-12 |
1988-06-21 |
The Regents Of The University Of California |
Expression of glycosylated human influenza hemagglutinin proteins
|
|
US4753788A
(en)
|
1985-01-31 |
1988-06-28 |
Vestar Research Inc. |
Method for preparing small vesicles using microemulsification
|
|
IL78775A
(en)
|
1985-05-15 |
1992-06-21 |
Biotech Australia Pty Ltd |
Oral vaccines
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US4728578A
(en)
|
1986-08-13 |
1988-03-01 |
The Lubrizol Corporation |
Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers
|
|
WO1988001873A1
(en)
|
1986-09-22 |
1988-03-24 |
Emory University |
Vaccine and method of preparation
|
|
NZ219516A
(en)
|
1987-02-10 |
1991-02-26 |
Wellcome Found |
Fusion proteins of hbcag (hepatitis b virus core antigen)
|
|
NZ219515A
(en)
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
|
CA1340817C
(en)
|
1988-05-05 |
1999-11-09 |
Salete Maria Cardozo Newton |
Recombinant flagellin vaccines
|
|
US6130082A
(en)
|
1988-05-05 |
2000-10-10 |
American Cyanamid Company |
Recombinant flagellin vaccines
|
|
US4935171A
(en)
|
1989-01-27 |
1990-06-19 |
Vestar, Inc. |
Method for vesicle formation
|
|
US5709879A
(en)
|
1990-06-29 |
1998-01-20 |
Chiron Corporation |
Vaccine compositions containing liposomes
|
|
US5500366A
(en)
|
1990-09-18 |
1996-03-19 |
Biotech Australia Pty. Ltd. |
Polynucleotide encoding T-cell epitopes of the protein TraT
|
|
US5290686A
(en)
|
1991-07-31 |
1994-03-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Expression of influenza a M2 protein in baculovirus
|
|
AU681572B2
(en)
|
1991-10-21 |
1997-09-04 |
Med Immune, Inc. |
Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
|
|
US5877289A
(en)
|
1992-03-05 |
1999-03-02 |
The Scripps Research Institute |
Tissue factor compositions and ligands for the specific coagulation of vasculature
|
|
IL101639A0
(en)
|
1992-04-17 |
1992-12-30 |
Yeda Res & Dev |
Recombinant influenza vaccines
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
US5464933A
(en)
*
|
1993-06-07 |
1995-11-07 |
Duke University |
Synthetic peptide inhibitors of HIV transmission
|
|
ES2370937T3
(es)
|
1993-09-13 |
2011-12-23 |
Protein Sciences Corporation |
Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
|
|
US5976552A
(en)
|
1995-04-28 |
1999-11-02 |
Protein Sciences Corporation |
Virus vaccines
|
|
US5762939A
(en)
|
1993-09-13 |
1998-06-09 |
Mg-Pmc, Llc |
Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
|
|
EP0733113B1
(en)
|
1994-01-11 |
2007-05-02 |
Vlaams Interuniversitair Instituut voor Biotechnologie |
Influenza vaccine
|
|
US6764682B1
(en)
*
|
1994-06-16 |
2004-07-20 |
Aventis Pasteur Limited |
Adjuvant compositions containing more than one adjuvant
|
|
US5612037A
(en)
|
1994-07-26 |
1997-03-18 |
Connaught Laboratories, Inc. |
Influenza virus subunit conjugates
|
|
US5512294A
(en)
|
1994-08-05 |
1996-04-30 |
Li; King C. |
Targeted polymerized liposome contrast agents
|
|
US6132764A
(en)
|
1994-08-05 |
2000-10-17 |
Targesome, Inc. |
Targeted polymerized liposome diagnostic and treatment agents
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
FR2723849B1
(fr)
|
1994-08-31 |
1997-04-11 |
Biovector Therapeutics Sa |
Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique
|
|
AU716806B2
(en)
|
1995-04-17 |
2000-03-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
|
|
SE9604322D0
(sv)
|
1996-11-25 |
1996-11-25 |
Astra Ab |
Bacterial antigens and vaccine compositions II
|
|
EP1005368B1
(en)
|
1997-03-10 |
2009-09-02 |
Ottawa Hospital Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants
|
|
CA2286210A1
(en)
|
1997-04-18 |
1998-10-29 |
Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) |
Attenuated salmonella strain used as a vehicle for oral immunization
|
|
ATE432348T1
(de)
|
1997-06-06 |
2009-06-15 |
Univ California |
Inhibitoren von immunstimulatorischen dna sequenz aktivität
|
|
US7731972B1
(en)
|
2000-02-04 |
2010-06-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
Immunoprotective influenza antigen and its use in vaccination
|
|
ES2255181T3
(es)
|
1997-08-05 |
2006-06-16 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Antigeno inmunoprotector contra la gripe y su uso en vacunacion.
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
US6060308A
(en)
*
|
1997-09-04 |
2000-05-09 |
Connaught Laboratories Limited |
RNA respiratory syncytial virus vaccines
|
|
DK1027063T3
(da)
|
1997-09-29 |
2009-06-02 |
Macfarlane Burnet Inst For Med |
Mannosereceptorbærende cellelinje og antigensammensætning
|
|
US6440736B1
(en)
|
1998-10-16 |
2002-08-27 |
U-Bisys B.V. |
Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
|
|
US6086881A
(en)
|
1998-05-15 |
2000-07-11 |
Children's Medical Center Corp. |
Spatially aligned conjugated composition having a thioether bond linkage
|
|
TWI229679B
(en)
|
1998-06-20 |
2005-03-21 |
United Biomedical Inc |
Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
|
|
IL127331A0
(en)
|
1998-11-30 |
1999-09-22 |
Yeda Res & Dev |
Peptide-based vaccine for influenza
|
|
AU4709401A
(en)
|
1999-11-29 |
2001-06-12 |
Inotek Corporation |
Composition and method for treating a microbial infection
|
|
EP1237911A2
(en)
*
|
1999-12-06 |
2002-09-11 |
Whitehead Institute For Biomedical Research |
Inhibition of hrsv membrane fusion
|
|
DE60132427D1
(de)
|
2000-02-18 |
2008-03-06 |
Vlaams Interuniv Inst Biotech |
Gebrauch von opri lipoprotein aus pseudomonas als th1 induzierendes natürliches adjuvans für heterologe antigene
|
|
AU2001264824A1
(en)
*
|
2000-06-01 |
2001-12-11 |
St. Jude Children's Research Hospital |
Vaccine and gene therapy vector and methods of use thereof
|
|
EP1294892B1
(en)
|
2000-06-23 |
2007-10-17 |
Wyeth Holdings Corporation |
Assembly of wild-type and chimeric influenza virus-like particles (vlps)
|
|
US20030232055A1
(en)
|
2000-07-31 |
2003-12-18 |
Ruslan Medzhitov |
Innate immune system-directed vaccines
|
|
US20020061312A1
(en)
|
2000-07-31 |
2002-05-23 |
Ruslan Medzhitov |
Innate immune system-directed vaccines
|
|
WO2002009748A1
(en)
|
2000-07-31 |
2002-02-07 |
Yale University |
Innate immune system-directed vaccines
|
|
ATE412666T1
(de)
*
|
2000-10-18 |
2008-11-15 |
Us Gov Health & Human Serv |
Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
|
|
AU2002223275A1
(en)
*
|
2000-11-22 |
2002-06-03 |
Biota Scientific Management Pty Ltd |
A method of expression and agents identified thereby
|
|
US20030175287A1
(en)
|
2001-01-03 |
2003-09-18 |
Yale University |
Innate immune system-directed vaccines
|
|
ATE433491T1
(de)
|
2001-01-18 |
2009-06-15 |
Vlaams Interuniv Inst Biotech |
Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential
|
|
EP1379552B2
(en)
|
2001-04-20 |
2014-11-19 |
The Institute for Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
US8703146B2
(en)
|
2001-04-20 |
2014-04-22 |
Institute For Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
US7361352B2
(en)
|
2001-08-15 |
2008-04-22 |
Acambis, Inc. |
Influenza immunogen and vaccine
|
|
WO2003102165A2
(en)
|
2002-02-21 |
2003-12-11 |
Apovia, Inc. |
IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE
|
|
US20030175863A1
(en)
|
2001-08-15 |
2003-09-18 |
Birkett Ashley J. |
Influenza immunogen and vaccine
|
|
ATE447967T1
(de)
|
2001-09-14 |
2009-11-15 |
Cytos Biotechnology Ag |
Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
|
|
WO2003051305A2
(en)
|
2001-12-14 |
2003-06-26 |
Yale University |
Innate immune system-directed vaccines
|
|
US7285289B2
(en)
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
|
CA2517074A1
(en)
|
2003-02-27 |
2004-09-10 |
Yeda Research And Development Co., Ltd. |
Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
|
|
MXPA05009580A
(es)
|
2003-03-07 |
2005-10-19 |
Merck & Co Inc |
Vacuna contra el virus de la influenza.
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
WO2005042564A1
(en)
*
|
2003-10-20 |
2005-05-12 |
Sidney Kimmel Cancer Center |
Flagellin fusion proteins as adjuvants or vaccines and methods of use
|
|
WO2005072088A2
(en)
*
|
2003-12-11 |
2005-08-11 |
Sciperio, Inc. |
Immunotherapy compositions, method of making and method of use thereof
|
|
WO2005077408A2
(en)
|
2004-02-06 |
2005-08-25 |
Vaxinnate Corporation |
Compositions of pamps and listeria monocytogenes and methods of use
|
|
EP1793850A4
(en)
*
|
2004-09-21 |
2010-06-30 |
Medimmune Inc |
ANTIBODIES TO THE METHOD AND METHOD FOR THE PRODUCTION OF VACCINES AGAINST THE RESPIRATORY SYNCYTIAL VIRUS
|
|
WO2006039701A1
(en)
|
2004-10-01 |
2006-04-13 |
University Of South Florida |
Flagellin-based adjuvants and vaccines
|
|
DE102004049223A1
(de)
|
2004-10-08 |
2006-04-20 |
Johannes-Gutenberg-Universität Mainz |
Zubereitung zum Impfen, Impfverfahren und Verwendung einer Impf-Zubereitung
|
|
EP3312272B1
(en)
*
|
2004-10-08 |
2019-08-28 |
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services |
Modulation of replicative fitness by using less frequently used synonymous codons
|
|
TW200636064A
(en)
*
|
2004-10-28 |
2006-10-16 |
Centocor Inc |
Anti-respiratory syncytial virus antibodies, antigens and uses thereof
|
|
EP1827489B1
(en)
|
2004-12-16 |
2012-10-31 |
Wake Forest University Health Sciences |
Use of flagellin in tumor immunotherapy
|
|
US20090162400A1
(en)
|
2004-12-21 |
2009-06-25 |
Powell Thomas J |
Compositions of influenza viral proteins and methods of use thereof
|
|
JP2008524261A
(ja)
|
2004-12-21 |
2008-07-10 |
バクシネート コーポレーション |
インフルエンザウイルスタンパク質の組成物およびその使用方法
|
|
HU227285B1
(en)
*
|
2004-12-29 |
2011-01-28 |
Mta Enzimologiai Intezet |
Modified flagellins and flagellar filaments useful as receptors and processes for producing same
|
|
JP2008527009A
(ja)
|
2005-01-19 |
2008-07-24 |
バクシネート コーポレーション |
病原体関連分子パターンおよび抗原を含む組成物ならびに免疫応答を刺激するためのそれらの使用
|
|
CA2596248A1
(en)
|
2005-01-31 |
2006-08-10 |
Vaxinnate Corporation |
Method to identify polypeptide toll-like receptor (tlr) ligands
|
|
CA2596079A1
(en)
|
2005-01-31 |
2006-08-10 |
Vaxinnate Corporation |
Novel polypeptide ligands for toll-like receptor 2 (tlr2)
|
|
EP1863529A1
(en)
|
2005-03-23 |
2007-12-12 |
GlaxoSmithKline Biologicals S.A. |
Novel composition
|
|
WO2006110214A2
(en)
*
|
2005-04-08 |
2006-10-19 |
Medimmune, Inc. |
Antibodies against mammalian metapneumovirus
|
|
WO2007022425A2
(en)
|
2005-08-16 |
2007-02-22 |
Hawaii Biotech, Inc. |
Influenza recombinant subunit vaccine
|
|
CU23578A1
(es)
*
|
2005-09-16 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
|
|
US20070111331A1
(en)
*
|
2005-11-16 |
2007-05-17 |
Chin-Yih Rex Hong |
Diagnostic methods using magnetic nanoparticles
|
|
WO2007066334A1
(en)
|
2005-12-06 |
2007-06-14 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved influenza vaccine
|
|
HUE049580T2
(hu)
|
2006-01-27 |
2020-09-28 |
Seqirus Uk Ltd |
Hemagglutinint és mátrixfehérjéket tartalmazó, influenza elleni oltóanyagok
|
|
EP2476432B1
(en)
|
2006-03-07 |
2015-08-19 |
Vaxinnate Corporation |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
WO2007120818A2
(en)
|
2006-04-12 |
2007-10-25 |
Massachusetts Institute Of Technology |
Compositions and methods for inhibiting adhesions
|
|
PL2010572T3
(pl)
*
|
2006-04-19 |
2014-05-30 |
Postech Acad Ind Found |
Białka fuzyjne zawierające polipeptydy HPV i peptydy wzmagające odporność do leczenia i zapobiegania rakowi szyjki macicy
|
|
WO2007125535A1
(en)
*
|
2006-05-01 |
2007-11-08 |
Biondvax Pharmaceuticals Ltd. |
Recombinant flagellin gene and uses thereof
|
|
JPWO2008010478A1
(ja)
|
2006-07-21 |
2009-12-17 |
公立大学法人横浜市立大学 |
フラジェリン変異体ワクチン
|
|
ES2539818T3
(es)
|
2007-08-02 |
2015-07-06 |
Biondvax Pharmaceuticals Ltd. |
Vacunas contra la gripe multiepitópicas multiméricas
|
|
WO2009073133A1
(en)
*
|
2007-11-29 |
2009-06-11 |
Vaxinnate Corporation |
Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof
|
|
WO2009082440A2
(en)
|
2007-12-18 |
2009-07-02 |
Vaxinnate Corporation |
Compositions of toll-like receptor agonists and malaria antigens and methods of use
|
|
SG190562A1
(en)
|
2008-04-18 |
2013-06-28 |
Vaxinnate Corp |
Deletion mutants of flagellin and methods of use
|
|
WO2009130618A2
(en)
|
2008-04-25 |
2009-10-29 |
Institute For Systems Biology |
Flagellin polypeptide vaccines
|
|
MX2012007916A
(es)
|
2010-01-06 |
2012-11-06 |
Vaxinnate Corp |
Metodos y composiciones para proporcionar inmunidad protectora en los adultos mayores.
|
|
WO2012115715A2
(en)
|
2011-02-21 |
2012-08-30 |
Vaxinnate Corporation |
Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use
|
|
BR112013021870A2
(pt)
|
2011-02-28 |
2016-11-22 |
Vaxlnnate Corp |
vacina contra dengue tetravalente e bivalente mista
|
|
EP2773674A4
(en)
|
2011-11-04 |
2015-04-29 |
Vaxinnate Corp |
IMMUNOLOGICAL CONSTRUCTIONS AND ASSOCIATED METHODS
|
|
US8932598B2
(en)
|
2012-08-28 |
2015-01-13 |
Vaxinnate Corporation |
Fusion proteins and methods of use
|